Capital International Investors Increases Holdings in agilon health, inc. (NYSE:AGL)

Capital International Investors increased its stake in shares of agilon health, inc. (NYSE:AGL - Free Report) by 72.0% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 22,331,873 shares of the company's stock after purchasing an additional 9,346,295 shares during the period. Capital International Investors owned approximately 5.42% of agilon health worth $42,431,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in AGL. Canada Pension Plan Investment Board purchased a new position in agilon health in the fourth quarter worth about $191,000. Raymond James Financial Inc. bought a new stake in agilon health during the fourth quarter valued at approximately $33,000. Renaissance Technologies LLC grew its position in agilon health by 155.1% during the fourth quarter. Renaissance Technologies LLC now owns 463,300 shares of the company's stock valued at $880,000 after buying an additional 281,700 shares during the period. Polymer Capital Management US LLC purchased a new stake in agilon health during the fourth quarter valued at approximately $57,000. Finally, Cerity Partners LLC bought a new position in agilon health in the fourth quarter worth approximately $34,000.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on AGL shares. Needham & Company LLC reissued a "hold" rating on shares of agilon health in a research report on Friday, March 21st. Robert W. Baird reduced their price target on agilon health from $6.00 to $5.00 and set a "neutral" rating for the company in a research report on Tuesday, April 15th. Citigroup raised agilon health from a "neutral" rating to a "buy" rating and lifted their price objective for the company from $3.25 to $5.00 in a research report on Friday. Sanford C. Bernstein raised shares of agilon health from a "market perform" rating to an "outperform" rating and increased their target price for the stock from $3.30 to $8.50 in a report on Tuesday, April 8th. Finally, Cowen reaffirmed a "hold" rating on shares of agilon health in a report on Tuesday, April 15th. Two analysts have rated the stock with a sell rating, twelve have issued a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, agilon health has an average rating of "Hold" and an average target price of $4.81.

agilon health Price Performance

NYSE AGL traded up $0.07 during trading on Friday, hitting $3.89. 3,612,723 shares of the stock traded hands, compared to its average volume of 4,830,383. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health, inc. has a 12-month low of $1.50 and a 12-month high of $7.73. The firm has a 50-day simple moving average of $4.19 and a 200-day simple moving average of $3.14. The company has a market capitalization of $1.61 billion, a P/E ratio of -4.14 and a beta of 0.38.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.